{
  "id": 5501770,
  "title": "Cipla slips after Qilu Pembrolizumab deal; Morgan Stanley flags crowded field",
  "url": "https://urgent.news/2026/09/04/cipla-slips-after-qilu-pembrolizumab-deal-morgan-stanley-flags",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-04T05:19:49.000Z",
  "source": {
    "name": "Hindu BusinessLine",
    "slug": "hindu-businessline",
    "url": "https://www.thehindubusinessline.com/markets/stock-markets/cipla-slips-after-qilu-pembrolizumab-deal-morgan-stanley-flags-crowded-field/article71427091.ece"
  },
  "original_language": "en",
  "account": "Cipla's shares dipped slightly on Friday as the company announced a partnership with China's Qilu Pharmaceutical to license and commercialize a biosimilar of Keytruda (pembrolizumab) in the United States. The stock closed at ₹1,388, down 0.48% from the previous close of ₹1,394.70. The deal strengthens Cipla's oncology and biosimilars portfolio, but Morgan Stanley warns of a crowded market with 13 other pembrolizumab biosimilars in development.",
  "summary": "Cipla stock trades at ₹1,388, down 0.48% or ₹6.70 from its previous close of ₹1,394.70",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 5,
    "also_reported_by": [
      {
        "outlet": "The Business Times - Companies & Markets",
        "title": "Morgan Stanley takes aim at X accounts posting its research",
        "url": "https://urgent.news/2026/09/04/morgan-stanley-takes-aim-at-x-accounts-posting-its-research",
        "published": "2026-09-04T00:29:16.000Z"
      },
      {
        "outlet": "Straits Times Business",
        "title": "Morgan Stanley takes aim at X accounts posting its research",
        "url": "https://urgent.news/2026/09/04/morgan-stanley-takes-aim-at-x-accounts-posting-its-research-5455770",
        "published": "2026-09-04T00:43:00.000Z"
      },
      {
        "outlet": "Expansion ES",
        "title": "Morgan Stanley abre la puerta a la corrección en Repsol",
        "url": "https://urgent.news/2026/09/04/morgan-stanley-abre-la-puerta-a-la-correccion-en-repsol",
        "published": "2026-09-04T07:25:08.000Z"
      },
      {
        "outlet": "Investing.com",
        "title": "Morgan Stanley upgrades Accor on 2027 RevPAR, cash-return inflection",
        "url": "https://urgent.news/2026/09/04/morgan-stanley-upgrades-accor-on-2027-revpar-cash-return-inflection",
        "published": "2026-09-04T09:13:28.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}